Trial Profile
Pattern and Clinical Implication of Lymph Node Metastasis From Gastric Cancer Which Was Resected by Radical Surgery With Extended Lymphadenectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 12 May 2019 Status changed from not yet recruiting to completed.
- 17 Nov 2015 Planned initiation date changed from 1 Oct 2015 to 1 Feb 2016, as reported by ClinicalTrials.gov.
- 26 May 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.